Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis

BACKGROUND: Previous studies have shown that xanthine oxidase inhibitors (XOI) might improve outcome for patients with cardiovascular disease. However, more evidence is required. METHODS AND RESULTS: We published a meta‐analysis of trials conducted before 2014 examining the effects of XOI on mortali...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jufen, Dierckx, Riet, Mohee, Kevin, Clark, Andrew L., Cleland, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292634/
https://www.ncbi.nlm.nih.gov/pubmed/28217311
http://dx.doi.org/10.1002/ehf2.12112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292634/
https://www.ncbi.nlm.nih.gov/pubmed/28217311
http://dx.doi.org/10.1002/ehf2.12112

Ejemplares similares